{"id":"https://openalex.org/W7162467795","doi":"https://doi.org/10.64898/2026.05.21.726884","title":"Intersection of Regulatory Analysis and Signature Reversion Uncovers Therapeutic Drugs and Targets for SETBP1 -HD","display_name":"Intersection of Regulatory Analysis and Signature Reversion Uncovers Therapeutic Drugs and Targets for SETBP1 -HD","alternate_titles":[],"publication_year":2026,"publication_date":"2026-05-26","ids":{"openalex":"https://openalex.org/W7162467795","doi":"https://doi.org/10.64898/2026.05.21.726884"},"language":"en","primary_location":{"id":"doi:10.64898/2026.05.21.726884","doi":"https://doi.org/10.64898/2026.05.21.726884","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.05.21.726884","pdf_url":null,"source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},"parent_works":[],"lineage":["https://openalex.org/W7162467795"],"child_works_count":0,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.64898/2026.05.21.726884","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110955177","display_name":"Elizabeth J. Wilk","orcid":"https://orcid.org/0000-0002-7078-1215","observed_orcids":["https://orcid.org/0000-0002-7078-1215"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4390039250","display_name":"UAB Medicine","ror":"https://ror.org/036554539","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039250"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth J. Wilk","raw_affiliation_strings":["The Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA"],"raw_orcid":"https://orcid.org/0000-0002-7078-1215","affiliations":[{"raw_affiliation_string":"The Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA","institution_ids":["https://openalex.org/I32389192","https://openalex.org/I4390039250"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5135607135","display_name":"Sasha Taluri","orcid":"https://orcid.org/0009-0005-1964-2120","observed_orcids":["https://orcid.org/0009-0005-1964-2120"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4390039250","display_name":"UAB Medicine","ror":"https://ror.org/036554539","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039250"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sasha Taluri","raw_affiliation_strings":["The Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA"],"raw_orcid":"https://orcid.org/0009-0005-1964-2120","affiliations":[{"raw_affiliation_string":"The Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA","institution_ids":["https://openalex.org/I32389192","https://openalex.org/I4390039250"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074650568","display_name":"Tabea M. Soelter","orcid":"https://orcid.org/0000-0003-1654-4240","observed_orcids":["https://orcid.org/0000-0003-1654-4240"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4390039250","display_name":"UAB Medicine","ror":"https://ror.org/036554539","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039250"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tabea M. Soelter","raw_affiliation_strings":["The Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA"],"raw_orcid":"https://orcid.org/0000-0003-1654-4240","affiliations":[{"raw_affiliation_string":"The Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA","institution_ids":["https://openalex.org/I32389192","https://openalex.org/I4390039250"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068868068","display_name":"Brittany N. Lasseigne","orcid":"https://orcid.org/0000-0002-1642-8904","observed_orcids":["https://orcid.org/0000-0002-1642-8904"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4390039250","display_name":"UAB Medicine","ror":"https://ror.org/036554539","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039250"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Brittany N. Lasseigne","raw_affiliation_strings":["The Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA"],"raw_orcid":"https://orcid.org/0000-0002-1642-8904","affiliations":[{"raw_affiliation_string":"The Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA","institution_ids":["https://openalex.org/I32389192","https://openalex.org/I4390039250"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5068868068"],"corresponding_institution_ids":["https://openalex.org/I32389192","https://openalex.org/I4390039250"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11772","display_name":"Genetics and Neurodevelopmental Disorders","score":0.9301999807357788,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11772","display_name":"Genetics and Neurodevelopmental Disorders","score":0.9301999807357788,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11642","display_name":"Genomics and Rare Diseases","score":0.030899999663233757,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.026100000366568565,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/setbp1","display_name":"SETBP1","score":0.9559999704360962},{"id":"https://openalex.org/keywords/lin28a","display_name":"LIN28A","score":0.843999981880188},{"id":"https://openalex.org/keywords/spon1","display_name":"SPON1","score":1.0},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.8870000243186951},{"id":"https://openalex.org/keywords/celecoxib","display_name":"celecoxib","score":0.9150000214576721},{"id":"https://openalex.org/keywords/buspirone","display_name":"buspirone","score":0.9980000257492065},{"id":"https://openalex.org/keywords/neurodevelopmental-disorders","display_name":"neurodevelopmental disorders","score":0.7099999785423279},{"id":"https://openalex.org/keywords/autism-spectrum-disorder","display_name":"autism spectrum disorder","score":0.9890000224113464},{"id":"https://openalex.org/keywords/neuroinflammation","display_name":"neuroinflammation","score":0.6990000009536743},{"id":"https://openalex.org/keywords/cyclooxygenase-2","display_name":"cyclooxygenase-2","score":0.8190000057220459},{"id":"https://openalex.org/keywords/neurogenesis","display_name":"neurogenesis","score":0.5699999928474426},{"id":"https://openalex.org/keywords/excitation-inhibition-balance","display_name":"excitation-inhibition balance","score":0.9520000219345093},{"id":"https://openalex.org/keywords/apraxia-of-speech","display_name":"apraxia of speech","score":0.6890000104904175},{"id":"https://openalex.org/keywords/motor-impairment","display_name":"motor impairment","score":0.8209999799728394}],"concepts":[{"id":"https://openalex.org/C103637391","wikidata":"https://www.wikidata.org/wiki/Q5308921","display_name":"Drug repositioning","level":3,"score":0.670799970626831},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.5080000162124634},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4894999861717224},{"id":"https://openalex.org/C6929976","wikidata":"https://www.wikidata.org/wiki/Q3771881","display_name":"Regulator","level":3,"score":0.4616999924182892},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.44909998774528503},{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.41920000314712524},{"id":"https://openalex.org/C68838962","wikidata":"https://www.wikidata.org/wiki/Q852654","display_name":"Haploinsufficiency","level":4,"score":0.40869998931884766},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.39579999446868896},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.3671000003814697},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3391999900341034},{"id":"https://openalex.org/C67339327","wikidata":"https://www.wikidata.org/wiki/Q1502576","display_name":"Gene regulatory network","level":4,"score":0.32659998536109924},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.3086000084877014},{"id":"https://openalex.org/C8415881","wikidata":"https://www.wikidata.org/wiki/Q6839217","display_name":"Microarray analysis techniques","level":4,"score":0.3021000027656555},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.296099990606308},{"id":"https://openalex.org/C152662350","wikidata":"https://www.wikidata.org/wiki/Q815297","display_name":"Systems biology","level":2,"score":0.28619998693466187},{"id":"https://openalex.org/C2777287423","wikidata":"https://www.wikidata.org/wiki/Q412194","display_name":"Buspirone","level":4,"score":0.2757999897003174},{"id":"https://openalex.org/C69125201","wikidata":"https://www.wikidata.org/wiki/Q2034716","display_name":"Axon guidance","level":3,"score":0.2587999999523163},{"id":"https://openalex.org/C519536355","wikidata":"https://www.wikidata.org/wiki/Q21021151","display_name":"Repurposing","level":2,"score":0.2542000114917755},{"id":"https://openalex.org/C33498276","wikidata":"https://www.wikidata.org/wiki/Q2138797","display_name":"Regulator gene","level":4,"score":0.25270000100135803},{"id":"https://openalex.org/C165864922","wikidata":"https://www.wikidata.org/wiki/Q411391","display_name":"Regulation of gene expression","level":3,"score":0.2500999867916107}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.64898/2026.05.21.726884","doi":"https://doi.org/10.64898/2026.05.21.726884","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.05.21.726884","pdf_url":null,"source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.64898/2026.05.21.726884","doi":"https://doi.org/10.64898/2026.05.21.726884","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.05.21.726884","pdf_url":null,"source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":97,"referenced_works":["https://openalex.org/W1533942137","https://openalex.org/W1964512314","https://openalex.org/W1967533656","https://openalex.org/W1977244336","https://openalex.org/W1979617003","https://openalex.org/W1993655511","https://openalex.org/W2002243924","https://openalex.org/W2008398629","https://openalex.org/W2060907567","https://openalex.org/W2077060302","https://openalex.org/W2097812689","https://openalex.org/W2102066368","https://openalex.org/W2110065044","https://openalex.org/W2112774187","https://openalex.org/W2114104545","https://openalex.org/W2115599658","https://openalex.org/W2120729861","https://openalex.org/W2125829114","https://openalex.org/W2138122783","https://openalex.org/W2146511318","https://openalex.org/W2146512944","https://openalex.org/W2155723007","https://openalex.org/W2156665896","https://openalex.org/W2163302580","https://openalex.org/W2164298117","https://openalex.org/W2341128841","https://openalex.org/W2406250479","https://openalex.org/W2462053388","https://openalex.org/W2513094297","https://openalex.org/W2541585197","https://openalex.org/W2558964899","https://openalex.org/W2603489941","https://openalex.org/W2606916385","https://openalex.org/W2606963524","https://openalex.org/W2608160060","https://openalex.org/W2612467560","https://openalex.org/W2738402542","https://openalex.org/W2770178180","https://openalex.org/W2782454362","https://openalex.org/W2785792383","https://openalex.org/W2807685640","https://openalex.org/W2884770325","https://openalex.org/W2896002881","https://openalex.org/W2901144895","https://openalex.org/W2917858269","https://openalex.org/W2927718321","https://openalex.org/W2952615074","https://openalex.org/W2963334956","https://openalex.org/W2979722852","https://openalex.org/W2990427812","https://openalex.org/W3006653136","https://openalex.org/W3042896257","https://openalex.org/W3080500495","https://openalex.org/W3093286766","https://openalex.org/W3112910474","https://openalex.org/W3155075117","https://openalex.org/W3158623875","https://openalex.org/W3215050216","https://openalex.org/W4220734682","https://openalex.org/W4225865462","https://openalex.org/W4281388173","https://openalex.org/W4285292934","https://openalex.org/W4296024012","https://openalex.org/W4306353209","https://openalex.org/W4310240482","https://openalex.org/W4321376025","https://openalex.org/W4375855550","https://openalex.org/W4376641767","https://openalex.org/W4377164202","https://openalex.org/W4379207569","https://openalex.org/W4379930282","https://openalex.org/W4384664789","https://openalex.org/W4387661643","https://openalex.org/W4387893771","https://openalex.org/W4388951843","https://openalex.org/W4390496207","https://openalex.org/W4400059776","https://openalex.org/W4402325681","https://openalex.org/W4402981380","https://openalex.org/W4404120530","https://openalex.org/W4404535307","https://openalex.org/W4406245521","https://openalex.org/W4406549272","https://openalex.org/W4407243500","https://openalex.org/W4407956796","https://openalex.org/W4409009532","https://openalex.org/W4409069766","https://openalex.org/W4415026956","https://openalex.org/W4415356284","https://openalex.org/W4416573070","https://openalex.org/W7098463221","https://openalex.org/W7125022462","https://openalex.org/W7126110521","https://openalex.org/W7127566947","https://openalex.org/W7160519980","https://openalex.org/W7160546701","https://openalex.org/W7160992184"],"related_works":["https://openalex.org/W4400059776","https://openalex.org/W7162020250","https://openalex.org/W4402981380","https://openalex.org/W3096214162","https://openalex.org/W4415026956","https://openalex.org/W4321376025","https://openalex.org/W6943252407","https://openalex.org/W3216213941","https://openalex.org/W4417178265"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"SETBP1":[2,6,50,58,77,91,103,128,212,239,303],"haploinsufficiency":[3],"disorder":[4,23],"(":[5,155,216],"-HD)":[7],"is":[8,37],"a":[9,44,64,90,166,298,311,329],"neurodevelopmental":[10],"condition":[11],"characterized":[12],"by":[13,26,238,316,324],"developmental":[14,151],"delay,":[15],"speech":[16,276],"apraxia,":[17],"motor":[18,186,273,354],"deficits,":[19],"and":[20,52,101,109,153,173,187,201,254,275,336,353],"autism":[21],"spectrum":[22],"(ASD),":[24],"caused":[25],"deficiency":[27,308],"of":[28,66,76,124,150,266,285],"the":[29,115,126,170,210,223,233,263,267,282,288,349],"transcription":[30],"factor":[31],"(TF)":[32],"SETBP1.":[33],"Since":[34],"current":[35],"management":[36],"limited":[38],"to":[39,88,105,185,219,231,287,310,347],"symptomatic":[40],"relief,":[41],"we":[42,84,113],"defined":[43,297],"robust":[45,258],"consensus":[46,93,127,143,248],"molecular":[47,183,300],"signature":[48,98],"for":[49,121,169,302],"-HD":[51,92,129],"prioritized":[53,199,211],"drugs":[54],"that":[55],"converge":[56],"with":[57,99,320,357],"regulatory":[59,108,134,213],"targets.":[60,111],"Methods":[61],"We":[62,95,296,333],"performed":[63],"meta-analysis":[65],"three":[67],"independent":[68],"transcriptomic":[69,86],"datasets":[70],"derived":[71,250],"from":[72,251],"in":[73,177,191,194,246,278,305,328],"vitro":[74],"models":[75],"deficiency.":[78],"Using":[79],"Robust":[80],"Rank":[81],"Aggregation":[82],"(RRA),":[83],"overcame":[85],"heterogeneity":[87],"establish":[89],"signature.":[94,131],"integrated":[96],"this":[97],"known":[100],"spatio-temporal-aware":[102],"interactions":[104],"prioritize":[106],"key":[107,148],"drug":[110,118,196],"Finally,":[112],"screened":[114],"LINCS":[116],"L1000":[117],"perturbation":[119],"database":[120],"compounds":[122],"capable":[123],"reversing":[125],"gene":[130],"Results":[132],"Our":[133,193],"analysis":[135,144],"yielded":[136],"potential,":[137],"critical":[138],"therapeutic":[139,205,264,340],"windows,":[140],"while":[141,180,222],"our":[142],"identified":[145,268],"LIN28A":[146,164,286,317],"(a":[147],"regulator":[149],"timing)":[152],"SPON1":[154,181],"F-spondin)":[156],"as":[157,203,338],"novel,":[158],"robustly":[159],"upregulated":[160],"targets":[161,209],"across":[162],"models.":[163,256],"provides":[165],"potential":[167],"mechanism":[168,301],"dysregulated":[171],"neurogenesis":[172],"progenitor":[174],"proliferation":[175],"observed":[176],"patient-derived":[178],"cells,":[179],"links":[182],"dysfunction":[184],"connectivity":[188,321],"deficits":[189,274],"seen":[190],"patients.":[192],"silico":[195,247],"repurposing":[197],"screens":[198],"celecoxib":[200,208,335],"buspirone":[202,226,337],"top":[204,339],"candidates.":[206],"Mechanistically,":[207],"target":[214],"COX-2":[215],"PTGS2":[217],")":[218],"mitigate":[220],"neuroinflammation,":[221],"potent":[224],"neuromodulator":[225],"chemically":[227],"stabilizes":[228],"vulnerable":[229],"circuits":[230],"correct":[232],"underlying":[234],"neurotransmitter":[235],"imbalance":[236],"driven":[237,315,323],"loss.":[240],"Limitations":[241],"This":[242],"study":[243],"relies":[244],"on":[245,270],"modeling":[249],"cell":[252],"culture":[253],"animal":[255],"While":[257],"statistical":[259],"thresholds":[260],"were":[261],"applied,":[262],"efficacy":[265],"candidates":[269],"behavioral":[271],"phenotypes\u2014specifically":[272],"apraxia\u2014requires":[277],"vivo":[279],"validation.":[280],"Additionally,":[281],"specific":[283],"contribution":[284],"ASD":[289],"phenotype":[290],"warrants":[291],"further":[292],"functional":[293],"characterization.":[294],"Conclusions":[295],"unified":[299],"-HD,":[304],"which":[306],"dosage":[307],"leads":[309],"delayed":[312],"neurogenic":[313],"state":[314],",":[318],"coupled":[319],"defects":[322],"SPON1,":[325],"ultimately":[326],"resulting":[327],"destabilized":[330],"excitation/inhibition":[331],"balance.":[332],"identify":[334],"candidates,":[341],"offering":[342],"an":[343],"immediate":[344],"translational":[345],"pathway":[346],"address":[348],"core":[350],"neurodevelopmental,":[351],"circuitry,":[352],"challenges":[355],"associated":[356],"SETBP1-":[358],"HD":[359],"variants.":[360]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7162467795","counts_by_year":[],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2026-05-27T00:00:00"}
